Table 1. Patients’ socio-demographic, clinical, and treatment characteristics (n = 836).
| Patient characteristic | Value* | |
|---|---|---|
| Age—years a , mean (SD) (n = 833) | 35 | (8.9) |
| Sex—male a | 324 | (38.8%) |
| Educational status a , (n = 795) | ||
| No education | 112 | (14.1%) |
| Primary | 267 | (33.6%) |
| Secondary | 330 | (41.5%) |
| Tertiary | 86 | (10.8%) |
| Marital status a , (n = 796) | ||
| Never married | 186 | (23.3%) |
| Married or cohabiting | 381 | (47.9%) |
| Divorced or separated | 136 | (17.1%) |
| Widowed | 93 | (11.7%) |
| Religion a , (n = 795) | ||
| Christian | 741 | (93.2%) |
| Muslim | 51 | (6.4%) |
| Other | 3 | (0.4%) |
| Substance use/misuse—yes a , (n = 686) | 144 | (21.0%) |
| Body Mass Index (kg/m2) a , mean (SD) (n = 419) | 20.6 | (3.38) |
| Employment status a , (n = 617) | ||
| Unemployed | 199 | (32.3%) |
| Not working/studying due to ill health | 73 | (11.8%) |
| Working full time | 299 | (48.5%) |
| Working part time | 46 | (7.5%) |
| HIV status disclosure (to family/friend/neighbor)—yes a , (n = 612) | 572 | (93.5%) |
| Functional status b , (n = 817) | ||
| Working | 677 | (82.9%) |
| Ambulatory | 113 | (13.8%) |
| Bed ridden | 27 | (3.3%) |
| WHO clinical stage b , d , (n = 830) | ||
| Stage I | 191 | (23.0%) |
| Stage II | 231 | (27.9%) |
| Stage III | 309 | (37.2%) |
| Stage IV | 99 | (11.9%) |
| First line drug regimen b | ||
| TDF-containing | 434 | (51.9%) |
| AZT-containing | 322 | (38.5%) |
| d4T-containing | 80 | (9.6%) |
| CD4 cells/μL b , median (IQR) (n = 828) | 133.5 | (72-to-203) |
| Hemoglobin (g/dL) b , mean (SD) (n = 709) | 13.1 | (2.2) |
| Evidence of tuberculosis at or after start cART—yes, (n = 817) | 151 | (18.5%) |
| Months since HIV diagnosis b , median (IQR), (n = 822) | 1 | (0-to-7) |
| Months since start cART c , mean (SD), (n = 836) | 22.6 | (12.5) |
* values are n (%) unless otherwise indicated.
a at enrolment in HIV care.
b at start cART.
c at study entry or at last known clinic/pharmacy refill visit date.
d according to the revised World Health Organization clinical staging of HIV/AIDS for adults and adolescents, 2005 [51].
TDF, Tenofovir; AZT, Zidovudine; d4T, Stavudine.
SD, standard deviation; IQR, inter-quartile range.